Tandem Diabetes Care (TNDM) surged after posting record third-quarter sales and improved gross margins. The company brushed off the impact of a recent voluntary device correction earlier in the year.
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today presented new real-world insights from a survey on Tandem Mobi ...
Zacks Investment Research on MSN
Reasons to hold Tandem Diabetes stock in your portfolio for now
Tandem Diabetes Care, Inc.’s TNDM impressive international expansion is expected to bolster growth in the upcoming quarters. The company’s impressive strategic initiatives provide a favorable ...
Earnings Call Insights: Tandem Diabetes Care, Inc. (TNDM) Q2 2025 Updated 2025 guidance projects $1 billion in worldwide sales, with approximately $700 million from the U.S. and $300 million ...
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a leading insulin delivery and diabetes technology company, today announced that t:slim X2 insulin pump users have delivered more ...
The Tandem Diabetes Care t:slim X2 Insulin Pump, which is compatible with glucose monitoring specialist Dexcom's G7 and G6 continuous glucose monitoring (CGM) systems, has been cleared for sale by ...
SAN DIEGO, November 04, 2025--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced it achieved ISO/IEC 27001:2022 ...
Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following investor ...
Tandem Diabetes Care Inc.’s Control-IQ+ automated insulin delivery system improved multiple measures of glycemic control in individuals with type 2 diabetes who use insulin, a study presented March 19 ...
Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended September 30, 2025 and reaffirmed full ...
Gross profit: GAAP gross profit was $157.5 million, compared to $93.3 million. GAAP gross margin was 56 percent, compared to 47 percent. Non-GAAP gross profit (1) was $127.9 million, compared to ...
Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback